{"id":3774,"date":"2024-06-18T11:49:01","date_gmt":"2024-06-18T09:49:01","guid":{"rendered":"https:\/\/ifevet.com\/uk\/?p=3774"},"modified":"2025-01-09T09:25:33","modified_gmt":"2025-01-09T09:25:33","slug":"management-of-hyperkalemia","status":"publish","type":"post","link":"https:\/\/ifevet.com\/uk\/management-of-hyperkalemia\/","title":{"rendered":"Management of Hyperkalemia"},"content":{"rendered":"
When should hyperkalemia be treated?<\/strong><\/p>\n It is usually from levels above 6.5 mEq\/L. Above 7.5 mEq\/L treatment should be more aggressive.<\/p>\n <\/p>\n \u00bfQu\u00e9 f\u00e1rmacos usamos para tratarla?<\/strong><\/p>\n <\/p>\n How often are values monitored once treatment is started?<\/strong><\/p>\n Your values should be monitored hourly until they are established in the < 6.5 mEq\/L range and remain stable there.<\/p>\n","protected":false},"excerpt":{"rendered":" When should hyperkalemia be treated? It is usually from levels above 6.5 mEq\/L. Above 7.5 mEq\/L treatment should be more aggressive. \u00bfQu\u00e9 f\u00e1rmacos usamos para tratarla? Drug Dose Mechanism of action Comments Calcium gluconate 10% 0.5 – 1.5 ml\/kg slow IV with ECG It reduces cardiac excitability by restoring the gradient between resting potential […]<\/p>\n","protected":false},"author":210,"featured_media":3775,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32],"tags":[],"class_list":["post-3774","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-content"],"yoast_head":"\n\n\n
\n Drug<\/strong><\/td>\n Dose<\/strong><\/td>\n Mechanism of action<\/strong><\/td>\n Comments<\/strong><\/td>\n<\/tr>\n \n Calcium gluconate 10%<\/td>\n 0.5 – 1.5 ml\/kg slow IV with ECG<\/td>\n It reduces cardiac excitability by restoring the gradient between resting potential and threshold.<\/td>\n It does not lower levels but provides cardoprotection.<\/td>\n<\/tr>\n \n Dextrose 50%<\/td>\n \u00a00.5 – 1.-5 ml\/kg slow IV<\/td>\n Promotes entry into the cell by activation of the Na-KATPase pump<\/td>\n Subsequently supplement serum with 2.5 – 5% glucose.<\/td>\n<\/tr>\n \n Insulin and dextrose 50%.<\/td>\n \u00a00.2 – 0.5 U\/kg of rapid insulin and 2-4 4ml of 50% glucose per unit of insulin<\/td>\n Promotes entry into the cell by activation of the Na-KATPase pump<\/td>\n Subsequently supplement serum with 2.5 – 5% glucose.<\/td>\n<\/tr>\n \n Sodium bicarbonate<\/td>\n 1-2 mEq\/kg IV slow 15 min<\/td>\n Increases extracellular pH and favours entry into the cell in exchange for hydrogen<\/td>\n <\/td>\n<\/tr>\n \n Terbutaline<\/td>\n 0.01 mg\/kg slow IV<\/td>\n Promotes entry into the cell by activation of the Na-KATPase pump<\/td>\n <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n